Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 101-02-0
Product Catalog
15-6850
Phosphorus › Triphenylphosphite, 97%| CAS Number: | 101-02-0 |
| MDL Number: | MFCD00003032 |
| Molecular Formula: | C18H15O3P |
| Molecular Weight: | 310.28 |
| Chemical Formula: | (C6H5O)3P |
| Color and Form: | white to yellow xtl. |
| Note: |
Physical Characteristics: melting point 22-24°C, boiling point 360°C, flash point 425°F, density 1.180-1.186
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Triphenylphosphite, 97% |
| Product Number: | 15-6850 |
| CAS Registry Number: | 101-02-0 |
| Formula: | (C6H5O)3P |
| EINECS Number: | 202-908-4 |
| Chemical Family: | organophosphorus compound |
| Synonym: | Phenyl phosphite ((C6H50)3P), Tris(phenoxy)phosphine, triphenoxyphosphine |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 101-02-0 | 100 | no data | no data |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Harmful if swallowed. May cause central nervous system effects. Irritating to skin, eyes and respiratory tract. |
| Primary Routes of Exposure: | Ingestion, inhalation |
| Eye Contact: | Causes severe irritation of the eyes |
| Skin Contact: | Causes moderate irritation of the skin. May cause allergic skin reaction. |
| Inhalation: | Irritating to the nose, mucous membranes and respiratory tract. |
| Ingestion: | Harmful if swallowed. Irritating to mouth, throat and stomach. May cause central nervous system effects. |
| Acute Health Effects: | Irritating to skin, eyes and respiratory tract. May inhibit cholinesterase activity, thereby inducing sleepiness, muscle weakness, tremor, and loss of peripheral nerve sensation. |
| Chronic Health Effects: | No information available on long term chromic effects. Under some conditions phenol may be slowly liberated. In animal studies phenol is a tumorigen, mutagen, and reproductive effector |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | 425°F |
| Autoignition Temperature: | no data |
| Explosion Limits: | no data |
| Extinguishing Medium: | dry chemical, carbon dioxide, or foam. |
| Special Fire Fighting Procedures: | Fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may emit toxic organic fumes, carbon monoxide, and phosphorous oxides. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite, sodium carbonate or other suitable non combustible adsorbent and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store in a cool, dry, well-ventilated area away from heat and direct sunlight. At elevated temperature this product may react slowly with air and moisture. Handle in a dry inert atmosphere. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Material may form a fine dust. Work with this product in a well-ventilated area, preferably a fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134 |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | white to yellow xtl |
| Molecular Weight: | 310.28 |
| Melting Point: | 22-24°C |
| Boiling Point: | 360°C |
| Vapor Pressure: | no data |
| Specific Gravity: | 1.180-1.186 |
| Odor: | phenol like odor |
| Solubility in Water: | insoluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | prolonged contact with air or moisture, especially at elevated temperature under alkaline conditions. |
| Incompatibility: | oxygen, oxidizing agents, sulfur, and halogens |
| Decomposition Products: | carbon dioxide, carbon monoxide, organic fumes, diphenylphosphonate, and phosphorus pentoxide. |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Administration onto the skin (human); Standard Draize test: 125 mg/48H. Administration onto the skin (rabbit); Standard Draize test): 500 mg. Administration into the eye (rabbit); Standard Draize test: 20 mg/24H. Administration into the eye (rabbit); Standard Draize test: 500 mg/24H. Oral (rat); LD50: 444 mg/kg. Inhalation (rat); LC: >6700 mg/m3/1H. Intraperitoneal (rat); LD50: 250 mg/kg. Subcutaneous (rat); LDLo: 2 gm/kg. Oral (mouse) LD50: 1080 mg/kg. Intraperitoneal (mouse); LD50: 266 mg/kg. Intraperitoneal (cat); LDLo: 100 mg/kg. Subcutaneous (cat); LDLo: 300 mg/kg. Administration onto the skin (rabbit); LDLo: 5 gm/kg. Subcutaneous (rat); TDLo: 3552 mg/kg/7D-I. |
| Carcinogenic Effects: | No data available |
| Mutagenic Effects: | No data available |
| Tetratogenic Effects: | No data available |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Avoid release to the environment. Very toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment. |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | This material and its container must be disposed of as hazardous waste according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory. |
| SARA (Title 313): | Title compound not listed. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 5/14/2001 |
| Revision Date: | 12/19/2011 |
